Duplex high resolution melting analysis (dHRMA) to detect two hot spot CYP24A1 pathogenic variants (PVs) associated to idiopathic infantile hypercalcemia (IIH)

被引：0
作者：
Maria De Bonis
Elisa De Paolis
Maria Elisabetta Onori
Giorgia Mazzuccato
Antonio Gatto
Pietro Ferrara
Pietro Manuel Ferraro
Andrea Urbani
Angelo Minucci
机构：
[1] Fondazione Policlinico Universitario A. Gemelli-IRCCS,UOS Diagnostica Molecolare E Genomica
[2] Fondazione Policlinico Universitario A. Gemelli-IRCCS,UOC Pediatria, Dipartimento Scienze della Salute della Donna, del Bambino E Di Sanità Pubblica
[3] UOC Nefrologia, Area Salute del Bambino
[4] Fondazione Policlinico Universitario A. Gemelli-IRCCS,undefined
[5] Università Cattolica del Sacro Cuore,undefined
来源：
Molecular Biology Reports | 2021年 / 48卷
关键词：
Idiopathic Infantile Hypercalcemia; Duplex assay; High resolution melting analysis; gene;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pathogenic variants (PVs) in CYP24A1 gene are associated with Idiopathic Infantile Hypercalcemia disease (IIH). The identification of CYP24A1 PVs can be a useful tool for the improvement of target therapeutic strategies. Aim of this study is to set up a rapid and inexpensive High Resolution Melting Analysis (HRMA)-based method for the simultaneous genotyping of two hot spot PVs in CYP24A1 gene, involved in IIH. A duplex-HRMA (dHRMA) was designed in order to detect simultaneously CYP24A1 c.428_430delAAG, p.(Glu143del) (rs777676129) and c.1186C > T, p.(Arg396Trp) (rs114368325), in peculiar cases addressed to our Laboratory. dHRMA was able to identify clearly and simultaneously both hot spot CYP24A1 PVs evaluating melting curve shape and melting temperature (Tm). This is the first dHRMA approach to rapidly screen the two most frequent CYP24A1 PVs in peculiar case, providing useful information for diagnosis and patient management in IIH disease.
引用
收藏
页码：3303 / 3311
页数：8
相关论文
共 153 条
  • [1] Lightwood R(1953)Idiopathic hypercalcaemia in infants Lancet 265 255-6
  • [2] Stapleton T(2018)Juvenile onset IIH and CYP24A1 mutations Bone Rep 9 42-46
  • [3] Schlingmann KP(2011)Mutations in CYP24A1 and idiopathic infantile hypercalcemia N Engl J Med 365 410-21
  • [4] Cassar W(2017)CYP24A1 loss of function: clinical phenotype of monoallelic and biallelic mutations J Steroid Biochem Mol Biol 173 337-340
  • [5] Konrad M(2019)Hereditary hypercalcemia caused by a homozygous pathogenic variant in the CYP24A1 gene: a case report and review of the literature Case Rep Endocrinol 2019 4982621-877
  • [6] Schlingmann KP(2019)Novel CYP24A1 mutation in a young male patient with nephrolithiasis: case report Kidney Blood Press Res 44 870-13
  • [7] Kaufmann M(2020)Vitamin D and kidney stones Urology 482 8-294
  • [8] Weber S(2018)A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH) Clin Chim Acta 45 291-204
  • [9] Irwin A(2017)A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass Urolithiasis 133 193-67
  • [10] Goos C(2016)Mutational spectrum of CYP24A1 gene in a cohort of italian patients with idiopathic infantile hypercalcemia Nephron 24 64-717
12345678910